Metraipolis › archive › dc_d53a1087f694
Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy — Europe PMC PMID:42347272
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42347272
- DOI
- 10.3390/nano16120705
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T17:01:12.700Z
- SHA-256 of the archived text
e650133931aa048cdc821b0c80b8fc9450650fe12bf8fe0990cb4264ae7c5e16- Stable URL of this page
https://metraipolis.com/documento/dc_d53a1087f694
How to cite
Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy — Europe PMC PMID:42347272 — Europe PMC (en), https://europepmc.org/article/MED/42347272 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d53a1087f694 (Metraipolis archive dc_d53a1087f694, sha256 e650133931aa048cdc821b0c80b8fc9450650fe12bf8fe0990cb4264ae7c5e16)
BibTeX
@misc{dcd53a1087f694,
title = {Development of PSMA-Targeted Liposomal Zinc for Prostate Cancer Therapy — Europe PMC PMID:42347272},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42347272},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d53a1087f694; sha256 e650133931aa048cdc821b0c80b8fc9450650fe12bf8fe0990cb4264ae7c5e16},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42347272. Agents can read the archived copy with the MCP tool read_document.